Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 307

1.

Burden of gastrointestinal and liver diseases in India, 1990-2016.

Shah D, Makharia GK, Ghoshal UC, Varma S, Ahuja V, Hutfless S.

Indian J Gastroenterol. 2018 Oct 10. doi: 10.1007/s12664-018-0892-3. [Epub ahead of print]

PMID:
30306342
2.

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India.

Agarwal A, Kedia S, Jain S, Gupta V, Bopanna S, Yadav DP, Goyal S, Mouli VP, Dhingra R, Makharia G, Ahuja V.

Intest Res. 2018 Oct;16(4):588-598. doi: 10.5217/ir.2018.00023. Epub 2018 Oct 10.

3.

First Degree Relatives of Patients with Celiac Disease Harbour an Intestinal Transcriptomic Signature that Might Protect them from Enterocyte Damage.

Acharya P, Kutum R, Pandey R, Mishra A, Saha R, Munjal A, Ahuja V, Mukerji M, Makharia GK.

Clin Transl Gastroenterol. 2018 Oct 8;9(10):195. doi: 10.1038/s41424-018-0059-7.

4.

Comparison of conventional methods of simultaneous intrusion and retraction of maxillary anterior: a finite element analysis.

Ahuja S, Gupta S, Bhambri E, Ahuja V, Jaura BS.

J Orthod. 2018 Oct 3:1-7. doi: 10.1080/14653125.2018.1525928. [Epub ahead of print]

PMID:
30280645
5.

Recovery Profile After General Anaesthesia in Paediatric Ambulatory Surgeries: Desflurane Versus Propofol.

Jain A, Gombar S, Ahuja V.

Turk J Anaesthesiol Reanim. 2018 Feb;46(1):21-27. doi: 10.5152/TJAR.2017.79990. Epub 2017 Nov 27.

6.

Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.

Hossain MS, Kumar A, Hossain AFMA, Mahshin M, Sharma A, Hossain MA, Sharma V, Haque R, Shamsuzzaman AKM, Maruf S, Ghosh P, Ahuja V, Mondal D.

Infect Dis Poverty. 2018 Aug 13;7(1):80. doi: 10.1186/s40249-018-0461-0.

7.

Selective M1 macrophage polarization in granuloma-positive and granuloma-negative Crohn's disease, in comparison to intestinal tuberculosis.

Das P, Rampal R, Udinia S, Kumar T, Pilli S, Wari N, Ahmed IK, Kedia S, Gupta SD, Kumar D, Ahuja V.

Intest Res. 2018 Jul;16(3):426-435. doi: 10.5217/ir.2018.16.3.426. Epub 2018 Jul 27.

8.

Regulation of emerging gene technologies in India.

Ahuja V.

BMC Proc. 2018 Jul 19;12(Suppl 8):14. doi: 10.1186/s12919-018-0106-0. eCollection 2018. Review.

9.

Clinical, endoscopic, and histological differentiation between celiac disease and tropical sprue: A systematic review.

Sharma P, Baloda V, Gahlot GP, Singh A, Mehta R, Vishnubathla S, Kapoor K, Ahuja V, Gupta SD, Makharia GK, Das P.

J Gastroenterol Hepatol. 2018 Aug 2. doi: 10.1111/jgh.14403. [Epub ahead of print]

PMID:
30069926
10.

An Interview with Dr. John L. Cameron, the Hall of Famer of Pancreatic Cancer.

Rivero-Soto RJ, Coleman J, Ahuja V.

J Gastrointest Surg. 2018 Oct;22(10):1842-1844. doi: 10.1007/s11605-018-3870-2. Epub 2018 Jul 18.

PMID:
30022442
11.

Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East.

Kedia S, Ahuja V.

Inflamm Intest Dis. 2017 Nov;2(2):102-115. doi: 10.1159/000465522. Epub 2017 Apr 8. Review.

12.

Molecular Insights into Antimicrobial Resistance Traits of Commensal Human Gut Microbiota.

Bag S, Ghosh TS, Banerjee S, Mehta O, Verma J, Dayal M, Desigamani A, Kumar P, Saha B, Kedia S, Ahuja V, Ramamurthy T, Das B.

Microb Ecol. 2018 Jul 16. doi: 10.1007/s00248-018-1228-7. [Epub ahead of print]

PMID:
30009332
13.

Analysis of the Gut Microbiome of Rural and Urban Healthy Indians Living in Sea Level and High Altitude Areas.

Das B, Ghosh TS, Kedia S, Rampal R, Saxena S, Bag S, Mitra R, Dayal M, Mehta O, Surendranath A, Travis SPL, Tripathi P, Nair GB, Ahuja V.

Sci Rep. 2018 Jul 4;8(1):10104. doi: 10.1038/s41598-018-28550-3.

14.

Is the emergence of inflammatory bowel disease a prime example of "the third epidemiological transition"?

Kedia S, Ahuja V.

Indian J Gastroenterol. 2018 May;37(3):183-185. doi: 10.1007/s12664-018-0852-y. Epub 2018 Jun 12. No abstract available.

PMID:
29948992
15.

Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease.

Kedia S, Jain S, Goyal S, Bopanna S, Yadav DP, Sachdev V, Sahni P, Pal S, Dash NR, Makharia G, Travis SPL, Ahuja V.

Dig Dis Sci. 2018 Oct;63(10):2747-2753. doi: 10.1007/s10620-018-5157-6. Epub 2018 Jun 8.

PMID:
29948556
16.

Diagnostic Accuracy of Point of Care Tests for Diagnosing Celiac Disease: A Systematic Review and Meta-Analysis.

Singh P, Arora A, Strand TA, Leffler DA, Mäki M, Kelly CP, Ahuja V, Makharia GK.

J Clin Gastroenterol. 2018 Jun 16. doi: 10.1097/MCG.0000000000001081. [Epub ahead of print]

PMID:
29912751
17.

Comparison of carotid plaque burden among healthy middle-aged men living in the US, Japan, and South Korea.

Vishnu A, Choo J, Kadota A, Barinas-Mitchell EJM, Fujiyoshi A, Long DL, Hisamatsu T, Ahuja V, Nakamura Y, Evans RW, Miura K, Masaki KH, Shin C, Ueshima H, Sekikawa A.

Int J Cardiol. 2018 Sep 1;266:245-249. doi: 10.1016/j.ijcard.2018.03.010.

PMID:
29887456
18.

Data on alcohol consumption and coronary artery calcification among asymptomatic middle-aged men for the ERA-JUMP study.

Mahajan H, Choo J, Masaki K, Fujiyoshi A, Guo J, Hisamatsu T, Evans R, Shangguan S, Willcox B, Okamura T, Vishnu A, Barinas-Mitchell E, Ahuja V, Miura K, Kuller L, Shin C, Ueshima H, Sekikawa A.

Data Brief. 2018 Feb 16;17:1091-1098. doi: 10.1016/j.dib.2018.02.032. eCollection 2018 Apr.

19.

Dysregulation of GABAergic Signalling Contributes in the Pathogenesis of Diarrhea-predominant Irritable Bowel Syndrome.

Aggarwal S, Ahuja V, Paul J.

J Neurogastroenterol Motil. 2018 Jul 30;24(3):422-430. doi: 10.5056/jnm17100.

20.

Management of inflammatory bowel disease in older persons: evolving paradigms.

Kedia S, Limdi JK, Ahuja V.

Intest Res. 2018 Apr;16(2):194-208. doi: 10.5217/ir.2018.16.2.194. Epub 2018 Apr 30. Review.

Supplemental Content

Loading ...
Support Center